Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 2 of 2 results for eplontersen

  1. Eplontersen for treating hereditary transthyretin-related amyloidosis (TA1020)

    Evidence-based recommendations on eplontersen (Wainzua) for treating hereditary transthyretin-related amyloidosis in adults.

    Technology appraisal guidance
    Published
    27 November 2024
    View recommendations

    Sections for TA1020

  2. Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy [TSID12015]

    Awaiting development Reference number: GID-TA11551 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development